29
May

Heron Therapeutics is gearing up for a third attempt at FDA approval for its chemotherapy-induced nausea and vomiting drug, posting a Phase III success after repeated delays.

…read more

Source: Heron soars as twice-rejected nausea drug comes through in Phase III

    

0 No comments